Publicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (26)

2022

  1. COX-2 Expression in Hepatocytes Improves Mitochondrial Function after Hepatic Ischemia-Reperfusion Injury

    Antioxidants, Vol. 11, Núm. 9

  2. Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

2021

  1. Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress

    Aging, Vol. 13, Núm. 6, pp. 7800-7827

2019

  1. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia–Reperfusion Injury in Mice

    Hepatology, Vol. 70, Núm. 2, pp. 650-665

2018

  1. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 2, pp. 325-337

  2. Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update

    World Journal of Gastroenterology, Vol. 24, Núm. 48, pp. 5454-5461

2016

  1. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1710-1723

2015

  1. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-box helicase p68 (DDX5) dependent: Role in insulin signaling

    Molecular and Cellular Biology, Vol. 35, Núm. 14, pp. 2554-2567

2013

  1. Identification of a novel Pfkfb1 mRNA variant in rat fetal liver

    Biochemical and Biophysical Research Communications, Vol. 431, Núm. 1, pp. 36-40

  2. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression

    Prostaglandins and Other Lipid Mediators, Vol. 106, pp. 106-115

  3. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma

    International Journal of Biochemistry and Cell Biology, Vol. 45, Núm. 11, pp. 2501-2511

2012

  1. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells

    PLoS ONE, Vol. 7, Núm. 11

  2. Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma

    Oncogenesis, Vol. 1, Núm. 7

2011

  1. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C

    Journal of Hepatology, Vol. 54, Núm. 1, pp. 142-152

  2. Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis

    American Journal of Pathology, Vol. 178, Núm. 3, pp. 1361-1373

2010

  1. COX-2 in liver, from regeneration to hepatocarcinogenesis: What we have learned from animal models?

    World Journal of Gastroenterology, Vol. 16, Núm. 12, pp. 1430-1435

2009

  1. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection. Constitutive COX-2 expression and cardioprotection

    Journal of Molecular and Cellular Cardiology, Vol. 46, Núm. 2, pp. 160-168

2008

  1. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury

    Biochemical Journal, Vol. 416, Núm. 3, pp. 337-346

2007

  1. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis

    Cardiovascular Research, Vol. 75, Núm. 4, pp. 803-812

  2. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes

    Hepatology, Vol. 45, Núm. 3, pp. 631-638